An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia

Update Il y a 4 ans
Reference: NCT01245530

Woman and Man

Extract

The purpose of this study is to evaluate the efficacy and safety of two fixed dose (1200mg/day, 1600mg/day) of INM-176 (a drug of treating dementia) comparing with donepezil for treatment for patients with Alzheimer type dementia.


Inclusion criteria

  • Alzheimer Type Dementia

Links